Pelago's Series C Funding to Enhance Care for Substance Use Disorders
Pelago Raises $58 Million in Series C
Pelago, a startup specializing in addiction care, recently secured $58 million in a Series C funding round led by Atomico. This substantial investment is set to enhance the company's services for individuals struggling with substance use disorders.
Expanding Substance Use Disorders Care
With the infusion of funds, Pelago aims to broaden its reach and efficacy in providing care for those affected by addiction issues. The company's focus on innovation and patient-centered solutions sets it apart in the healthcare industry.
Path to Profitability and Growth
Having attained this significant funding milestone, Pelago is on track to achieve profitability and sustainable growth. The funding round signals investor confidence in Pelago's mission and potential for making a positive impact in the addiction care landscape.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.